Showing results (31-40 of 5,643) with videos related to

Sort By:
Pageof 565
Drug Design, Development and Therapy|December 30, 2022
Anti-Inflammatory Activation of Phellodendri Chinensis Cortex is Mediated by Berberine Erythrocytes Self-Assembly Targeted Delivery SystemMinhua Li, Zehui Qin, Qiuxia Yu, et al.
Drug Design, Development and Therapy|January 4, 2023
Ketamine Attenuates Airway Inflammation via Inducing Inflammatory Cells Apoptosis and Activating Nrf2 Pathway in a Mixed-Granulocytic Murine Asthma ModelShilin Xiao, Ying Zhou, Qianyu Wang, et al.
Drug Design, Development and Therapy|June 14, 2022
Didymin Ameliorates Liver Fibrosis by Alleviating Endoplasmic Reticulum Stress and Glycerophospholipid Metabolism: Based on Transcriptomics and MetabolomicsYan Li, Cuiyu Li, Yuhua Xiong, et al.
Drug Design, Development and Therapy|June 2, 2022
Designing a Dual GLP-1R/GIPR Agonist from Tirzepatide: Comparing Residues Between Tirzepatide, GLP-1, and GIPLijing Wang
Drug Design, Development and Therapy|June 7, 2022
Determination of the Cut-off Value for Imatinib Plasma Levels Linked to Occurrence of Bone Pain in CML PatientsMarwa S Hamza, Samia A Shouman, Raafat Abdelfattah, et al.
Drug Design, Development and Therapy|June 7, 2022
Astragaloside IV Alleviates Renal Tubular Epithelial-Mesenchymal Transition via CX3CL1-RAF/MEK/ERK Signaling Pathway in Diabetic Kidney DiseaseYonghui Hu, Wangna Tang, Wenjie Liu, et al.
Drug Design, Development and Therapy|June 9, 2022
The Antithrombotic Effect of Recombinant Neorudin on ThrombiYu-Bin Liu, Lin Zhang, Xing-Chen Zhou, et al.
Drug Design, Development and Therapy|June 23, 2022
Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in TherapyChaudry Nasir Majeed, Christopher D Ma, Ted Xiao, et al.
Drug Design, Development and Therapy|December 6, 2022
Remimazolam Tosylate Combined with Low-Dose Propofol Improves Sedation and Safety in HysteroscopyFan Zhang, Huan Chang, Wenxiang Qing, et al.
Drug Design, Development and Therapy|November 28, 2022
Coffee and Caffeine Potentiate the Antiamyloidogenic Activity of Melatonin via Inhibition of Aβ Oligomerization and Modulation of theTau-Mediated Pathway in N2a/APP Cells [Retraction]
Pageof 565